Quantum Technology Missions Roadmap Opportunity

Open

Buyers

Value

£400,000

Classifications

  • Research and development services and related consultancy services

Tags

  • tender

Submission Deadline

2 weeks from now

Published

2 weeks ago

Description

Introduction and summary of requirements 

We would like individuals or organisations with commercial and technical knowledge of the quantum technology sector to develop detailed road maps to support the design and delivery of the National Quantum Strategy Missions.  

The focus of each road map will vary based on the characteristics of each Mission, as well as current evidence gaps that need addressing to inform policy development. The breadth and depth of specialist expertise required to deliver the road maps is substantial, spanning technical milestones for quantum entanglement networks to the identification of clinical use cases for quantum sensors. This opportunity has therefore been broken down into four separate lots to allow individuals or organisations with specific expertise relevant to individual Missions to participate.  

Aims and Objectives 

This project will gather evidence to help DSIT understand the key commercial opportunities, technology requirements and milestones, and dependencies for each Mission. This evidence will inform ongoing policy development and help shape policy interventions such as technology-specific innovation programmes, infrastructure investments and market creation activity to support overall Mission delivery.  

Alongside common evidence requirements for all lots (technology development timelines and underpinning requirements for priority use cases), there are specific requirements for each. These are outlined below:

Lot A: Quantum networking (Mission 2): technology and research milestones to materialise quantum networks, analysis of competing quantum networking components, underpinning classical infrastructure requirements

Lot B: Quantum sensing for healthcare (Mission 3): high potential clinical use case identification, mapping of necessary activity through the NHS HealthTech adoption framework

Lot C: Quantum position, navigation and timing (PNT) (Mission 4): market size estimates for core sub-component technologies such as compound semiconductors, MEMS vacuum cells, integrated photonics and advanced packaging.

Lot D: Quantum sensing for critical national infrastructure (CNI) (Mission 5): Current and future performance of sensing platforms, market size estimates for use cases such as gravity sensing in different sectors

Additional information: 
The ITT can be found on DSIT's e-procurement portal, Jaggaer, under live opportunities.

https://beisgroup.ukp.app.jaggaer.com/

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline active

Publish
Bid
Evaluate
Award
Complete